A study found hepatitis C patients continue to be at risk for hepatocellular carcinoma up to eight years after achieving a sustained virological response to antiviral treatment. Researchers from Sweden's Karolinska Institute said the risk was even higher for patients who did not reach SVR or who did not receive treatment.

Related Summaries